Oncology Product Manufacturing in a Nondedicated Facility

March 19, 2020
Baxter BioPharma Solutions

Sponsored Content

- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

Related Content:

Whitepapers